Nifty
:
24213.30
Sensex
:
79476.63
217.95 (0.91%)
694.39 (0.88%)
Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Balaxi Pharmaceuticals Ltd.

Finance - Investment

Rating :
N/A

BSE: Not Listed | NSE: BALAXI

NSE BSE
118.37
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  120.10
  •  120.99
  •  117.00
  •  119.51
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  17972
  •  21.41
  •  151.45
  •  80.22

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 496.70
  • 10.73
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 466.16
  • N/A
  • 2.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 65.99%
  • 3.68%
  • 9.24%
  • FII
  • DII
  • Others
  • 16.48%
  • 0.00%
  • 4.61%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 89.11
  • 39.53
  • -4.77

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 63.20
  • 40.11
  • -2.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 43.29
  • -10.90
  • -37.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.10

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
77.38
54.72
41.41%
65.62
65.95
-0.50%
59.83
80.68
-25.84%
60.79
86.58
-29.79%
Expenses
66.80
43.96
51.96%
55.54
57.11
-2.75%
46.37
67.94
-31.75%
47.13
71.29
-33.89%
EBITDA
10.59
10.76
-1.58%
10.09
8.84
14.14%
13.47
12.74
5.73%
13.66
15.29
-10.66%
EBIDTM
13.68%
19.67%
15.37%
13.40%
22.51%
15.79%
22.47%
17.66%
Other Income
-4.11
0.28
-
-1.85
-1.01
-
-1.79
-0.22
-
-0.13
-4.56
-
Interest
0.45
0.37
21.62%
0.37
0.29
27.59%
0.61
0.27
125.93%
0.42
0.01
4,100.00%
Depreciation
0.46
0.66
-30.30%
0.49
0.29
68.97%
0.67
1.19
-43.70%
0.48
0.19
152.63%
PBT
5.56
15.66
-64.50%
7.38
-39.41
-
11.49
11.07
3.79%
14.27
10.53
35.52%
Tax
0.97
1.23
-21.14%
0.89
1.93
-53.89%
0.56
2.97
-81.14%
0.68
2.30
-70.43%
PAT
4.59
14.43
-68.19%
6.48
-41.34
-
10.93
8.10
34.94%
13.59
8.23
65.13%
PATM
5.93%
26.37%
9.87%
-62.68%
18.27%
10.04%
22.36%
9.50%
EPS
0.83
2.82
-70.57%
1.17
-8.08
-
2.01
1.59
26.42%
2.66
1.64
62.20%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
263.62
241.29
336.43
279.39
231.33
45.63
13.60
Net Sales Growth
-8.44%
-28.28%
20.42%
20.78%
406.97%
235.51%
 
Cost Of Goods Sold
141.55
128.68
202.42
195.60
172.15
32.83
10.24
Gross Profit
122.07
112.61
134.02
83.79
59.19
12.81
3.36
GP Margin
46.31%
46.67%
39.84%
29.99%
25.59%
28.07%
24.71%
Total Expenditure
215.84
196.75
279.02
228.56
188.66
37.38
12.04
Power & Fuel Cost
-
0.04
0.28
0.35
0.00
0.00
0.00
% Of Sales
-
0.02%
0.08%
0.13%
0%
0%
0%
Employee Cost
-
28.04
28.95
12.47
8.47
2.10
0.90
% Of Sales
-
11.62%
8.61%
4.46%
3.66%
4.60%
6.62%
Manufacturing Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
General & Admin Exp.
-
24.17
35.00
14.98
5.28
2.34
0.61
% Of Sales
-
10.02%
10.40%
5.36%
2.28%
5.13%
4.49%
Selling & Distn. Exp.
-
0.66
0.84
1.02
0.10
0.10
0.21
% Of Sales
-
0.27%
0.25%
0.37%
0.04%
0.22%
1.54%
Miscellaneous Exp.
-
15.17
11.52
4.16
2.65
0.02
0.08
% Of Sales
-
6.29%
3.42%
1.49%
1.15%
0.04%
0.59%
EBITDA
47.81
44.54
57.41
50.83
42.67
8.25
1.56
EBITDA Margin
18.14%
18.46%
17.06%
18.19%
18.45%
18.08%
11.47%
Other Income
-7.88
0.63
2.64
4.97
2.23
0.59
0.89
Interest
1.85
2.77
1.38
0.76
0.28
0.05
0.00
Depreciation
2.10
2.10
1.75
0.51
0.30
0.01
0.00
PBT
38.70
40.31
56.92
54.52
44.33
8.79
2.44
Tax
3.10
4.40
10.96
6.86
6.19
2.69
0.47
Tax Rate
8.01%
217.82%
19.26%
12.58%
13.96%
30.60%
19.26%
PAT
35.59
-2.39
45.96
47.66
38.14
6.10
1.97
PAT before Minority Interest
35.59
-2.39
45.96
47.66
38.14
6.10
1.97
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
13.50%
-0.99%
13.66%
17.06%
16.49%
13.37%
14.49%
PAT Growth
436.39%
-
-3.57%
24.96%
525.25%
209.64%
 
EPS
6.45
-0.43
8.33
8.63
6.91
1.11
0.36

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
201.36
182.88
113.16
64.98
27.75
3.52
Share Capital
10.90
10.18
10.00
10.00
10.00
3.04
Total Reserves
186.69
162.40
103.16
54.98
17.75
0.48
Non-Current Liabilities
2.78
3.66
0.04
0.01
0.00
0.00
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.87
0.00
0.00
0.00
0.00
Long Term Provisions
0.04
0.00
0.00
0.00
0.00
0.00
Current Liabilities
54.20
53.13
63.27
34.69
8.22
2.59
Trade Payables
29.04
34.52
49.11
24.88
4.85
2.08
Other Current Liabilities
4.62
2.81
3.26
0.14
0.96
0.04
Short Term Borrowings
17.66
10.75
3.64
3.66
0.00
0.00
Short Term Provisions
2.88
5.06
7.25
6.01
2.42
0.47
Total Liabilities
258.34
239.67
176.47
99.68
35.97
6.11
Net Block
40.88
41.41
28.76
2.45
0.19
0.01
Gross Block
42.98
43.76
29.51
2.75
0.19
0.01
Accumulated Depreciation
2.10
2.35
0.76
0.30
0.00
0.00
Non Current Assets
48.17
46.16
35.47
5.91
1.11
0.33
Capital Work in Progress
2.31
2.83
0.57
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
3.42
0.00
0.00
Long Term Loans & Adv.
4.58
1.52
1.27
0.05
0.92
0.32
Other Non Current Assets
0.40
0.40
4.87
0.00
0.00
0.00
Current Assets
210.17
193.51
141.00
93.77
34.86
5.78
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
82.17
105.02
98.70
13.62
0.83
0.00
Sundry Debtors
55.71
52.28
27.56
76.76
29.71
5.47
Cash & Bank
62.29
28.22
7.19
1.67
4.00
0.13
Other Current Assets
10.01
3.78
3.90
0.77
0.31
0.17
Short Term Loans & Adv.
7.99
4.21
3.65
0.95
0.31
0.17
Net Current Assets
155.97
140.38
77.74
59.08
26.64
3.19
Total Assets
258.34
239.67
176.47
99.68
35.97
6.11

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
4.87
6.08
34.14
0.00
-14.04
-1.51
PBT
2.02
56.92
54.52
44.33
8.79
2.44
Adjustment
-1.14
8.03
1.18
-0.59
0.03
0.00
Changes in Working Capital
10.68
-46.79
-15.97
-41.14
-22.12
-3.94
Cash after chg. in Working capital
11.55
18.17
39.74
2.60
-13.29
-1.50
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.68
-12.09
-5.59
-2.59
-0.74
-0.01
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1.05
-10.57
-28.45
-5.97
-0.18
-0.01
Net Fixed Assets
1.66
-8.47
-2.33
-0.59
-0.18
Net Investments
-0.34
0.07
-0.07
-19.44
-0.10
Others
-2.37
-2.17
-26.05
14.06
0.10
Cash from Financing Activity
30.25
25.51
-0.16
3.65
18.10
0.00
Net Cash Inflow / Outflow
34.07
21.02
5.53
-2.32
3.88
-1.51
Opening Cash & Equivalents
28.21
7.19
1.66
3.98
0.10
1.62
Closing Cash & Equivalent
62.29
28.21
7.19
1.66
3.98
0.10

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
36.26
33.90
113.16
64.98
27.75
11.58
ROA
-0.96%
22.09%
34.52%
56.23%
29.01%
32.19%
ROE
-1.29%
32.17%
53.50%
82.26%
39.04%
55.84%
ROCE
2.31%
37.46%
59.62%
92.56%
56.56%
69.35%
Fixed Asset Turnover
5.56
9.18
17.32
157.71
461.40
1203.13
Receivable days
81.67
43.31
68.14
84.00
140.73
146.96
Inventory Days
141.58
110.51
73.37
11.40
6.66
0.00
Payable days
90.14
75.41
69.04
31.52
38.51
66.84
Cash Conversion Cycle
133.11
78.42
72.47
63.88
108.88
80.12
Total Debt/Equity
0.09
0.07
0.03
0.06
0.00
0.00
Interest Cover
1.73
42.34
72.69
160.34
184.97
1061.57

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Balaxi Pharma. - Quarterly Results
    2nd Aug 2024, 12:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.